NCT04279496Enrolling by invitation
Coronary CT Angiography Evaluation for Clinical Outcomes: An International Multicenter Registry
Coronary CT Angiography Evaluation for Clinical Outcomes: An International Multicenter
Source: ClinicalTrials.gov · Last updated 5 Jun 2026
Brief summary (registry, in English)
The overall objective of CONFIRM2 is to perform the largest cardiovascular phenotype outcomes study ever.
- Status (registry)
- Enrolling by invitation
- Study type
- Observational
- Enrollment
- 15000 (estimated)
- First submitted
- 19 Feb 2020
- Start date
- Jun 2020
- Primary completion date
- Jun 2027
- Lead sponsor
- Cleerly, Inc.
- Diseases
- Coronary artery disease
- NCT number
- NCT04279496
What you commit to
- Study type: Observational
- Planned participants: 15000
- From Jun 2020 to the primary completion date, Jun 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Age
- Non-cardiac illness with life expectancy \< 2 years
Other
- Individuals unable to provide informed consent
- Pregnancy
Who the study is looking for
- Age \>18 years
- Undergoing clinically indicated CCTA with \>64-detector row CT
- Signed informed consent, including of release of medical information, long term follow-up and Health Insurance Portability and Accountability Act (HIPAA) documentation
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University of Virginia Coordinator of this site? Confirm its status | Charlottesville | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.